Now, a 4-in-1 vaccine from Shanta Biotech

Shantha Biotechnics Ltd on Friday announced the availability of 'Shantetra', a combination vaccine against diphtheria, tetanus, pertussis and hepatitis-B, claimed to be the first indigenously......

Shantha Bio to raise $30m for trials

City-based Shantha Biotechnics Pvt Ltd is slated to raise close to $30 million from a strategic investor to further Phase I trials of its four monoclonal molecules for cancer treatment.Shantha will......

Govt approves FDI worth Rs 4,000 cr in pharma sector

Torrent Pharmaceuticals' Rs 3,000 crore proposal for increasing FII investment limit to 35 per cent was the biggest in terms of value Proposals for foreign direct investment amounting to around Rs......

Govt earns huge tax from big corporate deals

As corporate India unlocks value through mega deals, the Union government is smiling all the way to the bank.The government is likely to earn Rs 7,000 crore (Rs 70 billion) tax in the current......